Resultados de la búsqueda 151-160 of 3343 for Organophosphate poisoning

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the association between a baseline comprehensive geriatric assessment (cGA) and chemotherapy toxicity in the first ...

  2. Neurología - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. The purpose of this study is to evaluate the safety, pharmacokinetics and biodistribution of an imaging agent, 18F-OP-801 (18F Hydroxyl ...

  3. Radiología - Ensayos clínicos - Mayo Clinic

    ... toxicity including t-MN in radiotheranostic treated solid tumor patients. Image-based Mapping Of Brain Tumors. Scottsdale/Phoenix, Ariz., Rochester, Minn ...

  4. Mayo Clinic Physician Update - May 2025

    Page 1.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...

  6. Intoxicación por alcohol - Síntomas y causas - Mayo Clinic

    Alcohol poisoning deaths. Centers for Disease Control and Prevention. https ... Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...